NCT07498595 2026-03-27
TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC
Tianjin Medical University General Hospital
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
3 trialsNCT06979661 2025-05-20
PORT
Rutgers, The State University of New Jersey
Phase EARLY_PHASE1 Not yet recruiting
NCT06557096 2024-08-16
CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC
Second Affiliated Hospital of Nanchang University
Phase EARLY_PHASE1 Not yet recruiting